Letter: Splenic Lymphoma in a Patient Treated with Interleukin-2 and Dacarbazine for Metastatic Melanoma

Eitan Shiloni Department of Surgery, Hadassah University Hospital, Jerusalem, Israel

Kenneth A. Maclennan Department of Histopathology, The Royal Marsden Hospital, London, UK

Elimelech Okon The Royal Marsden Hospital, London, UK

Aaron Polliack Departments of Pathology and Hematology, Hadassah University Hospital, Jerusalem, Israel

References

Luce I. K. Chemotherapy of malignant melanoma. Cancer 1972; 30: 1604–1615
PubMed Web of Science ®Google Scholar
Rosenberg S. A., Lotze M. T., Yang J. C., et al. Experience with the use of high dose interleukin-2 in the treatment of 652 cancer patients. Ann Surg. 1989; 210: 474–485
PubMed Web of Science ®Google Scholar
Allison M. A., Jones S. E., McGuffey P. Phase II trial of outpatient interleukin-2 in malignant lymphoma, chronic lymphocytic leukemia and selected solid tumors. J. Clin. Oncol. 1989; 7: 75–80
PubMed Web of Science ®Google Scholar
Stoter G., Aamdal S., Rodenhuis S., et al. Sequential administration of recombinant human Interleukin-2 and Dacarbazine in metastatic melanoma. A multicenter phase II study. J. Clin. Oncol 1992, (in press)
Web of Science ®Google Scholar
Flaherty L. E., Schwert R., Redman B. G. Case report: Development of Hodgkin's disease in patient receiving long-term administration of dacarabazine and a Interleukin-2 for metastatic melanoma. J. Natl. Cancer Inst. 1990; 82: 1360
PubMed Web of Science ®Google Scholar

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Letter: Splenic Lymphoma in a Patient Treated with Interleukin-2 and Dacarbazine for Metastatic Melanoma

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Letter: Splenic Lymphoma in a Patient Treated with Interleukin-2 and Dacarbazine for Metastatic Melanoma

References

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date